30 July 2024
Baker McKenzie advises KD Pharma Group on the acquisition of the marine lipids business of dsm-firmenich in exchange for a minority stake in the company
Advising firms
Deal team
1 lawyer named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Dr Tino Marz Lead | Baker McKenzie | Partner | Corporate/M&A | Not stated |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- KD Pharma GroupBuy-side
- Counterparties
- dsm-firmenich (Sell-side)